简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2015-11-17 10:13 Replicor Discloses Continued Improvement of the Antiviral Response in Patients with HBV / HDV Co-Infection Receiving REP 2139-Ca Based Combination Therapy
2015-11-16 09:54 New Analyses Further Add to the Efficacy and Safety Profile of OFEV® (nintedanib) in Idiopathic Pulmonary Fibrosis (IPF)
2015-11-13 16:12 In New Study EMMA™ Capnograph Has Comparable Accuracy to Sidestream Capnography Against Gold-Standard Blood Gas Analysis
2015-11-12 17:08 Taiyo Pacific Partners Becomes Major Shareholder in JIN Co., Ltd. with Stake over 5%
2015-11-12 15:48 New Dimension of Natural Beauty in Hong Kong
2015-11-12 15:33 Replicor Announces Publication of Its Pre-Clinical Data on the Therapeutic Effect of NAPs on Hepatitis B Virus Infection.
2015-11-12 10:42 Boehringer Ingelheim Will Invest 11 Billion Euros in Research and Development in the Next Five Years to Accelerate the Discovery of Next Generation Medical Breakthroughs
2015-11-11 16:45 C2 Therapeutics Announces New Data Confirming Efficacy and Safety of Coldplay CryoBalloon® Focal Ablation System to Treat Esophageal Disease
2015-11-11 10:00 Boehringer Ingelheim Announces Completed Enrollment of Phase III Clinical Trial for Biosimilar Candidate to Adalimumab
2015-11-11 09:54 Boehringer Ingelheim partners with leading scientific institutions in inflammatory bowel disease research
2015-11-10 16:27 Real-World Analysis of more than 44,000 Patients Reinforces Safety and Effectiveness of Pradaxa® in Routine Clinical Care
2015-11-10 16:10 Boehringer Ingelheim Presents New idarucizumab (Praxbind®) Analyses on Reintroduction of Antithrombotic Therapy after Reversal of Dabigatran
2015-11-10 15:54 Quintiles Contributes Open Source Code to ResearchKit
2015-11-10 11:12 Allianz Worldwide Care Named ‘Best International Private Health Insurance Provider’ at Industry Awards
2015-11-10 11:00 MetLife Hong Kong Recruits Near 500 Agents Within a Year and Launches New “Go Goal Life” Campaign to Attract Generation Y Talent
2015-11-10 10:05 New Jardiance® (empagliflozin) data show improved CV outcomes regardless of heart failure status at baseline
2015-11-10 09:58 Replicor Announces Grant of US Patents on HBV / HDV Treatment Methods Combining HBsAg Reduction and Immunotherapy
2015-11-09 16:58 Takeda to Present Data from Ixazomib’s Phase 3 Study in Relapsed/Refractory Multiple Myeloma at Upcoming American Society of Hematology Annual Meeting
2015-11-09 16:51 Founder Dennis Gillings to Retire as Quintiles Executive Chairman at Close of 2015
2015-11-09 14:45 Research Finds Cranberries are an Effective Approach to Help Reduce Antibiotic Use

Business Wire Weibo

Press Releases

Latest Releases